Retrospective Application of Population Pharmacokinetic Model-Based Dosing for Fludarabine in Allogeneic Hematopoietic Cell Transplant for Inborn Errors of Immunity

Key Points

• Effective fludarabine dosing is achieved through population pharmacokinetic modeling, optimizing treatment.
• The analysis includes data from multiple patients with inborn errors of immunity, enhancing reliability.
• Retrospective analysis of pharmacokinetic data supports personalized dosing strategies in hematopoietic cell transplants.
• These findings emphasize the need for tailored treatments to improve outcomes in immunocompromised patients.